The programming of cardiovascular disease

Journal of Developmental Origins of Health and Disease

Volumn 6, Issue 5, 2015, Pages 366-376

  Thornburg, K L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

epigenetics; fetal programming; heart disease; roots of cardiovascular disease; worsening health

Indexed keywords

CARDIOVASCULAR DISEASE; EMBRYOLOGY; FEMALE; FETUS DEVELOPMENT; FETUS DISEASE; HEART; HUMAN; PATHOPHYSIOLOGY; PREGNANCY;

CARDIOVASCULAR DISEASES; FEMALE; FETAL DEVELOPMENT; FETAL DISEASES; HEART; HUMANS; PREGNANCY;

EID: 84948143659     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174415001300     Document Type: Review

References (106)

1. Chobanian AV. Shattuck Lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med. 2009; 361, 878-887.
2. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005; 112, 1651-1662.
3. Sarafidis PA, Georgianos P, Bakris GL. Resistant hypertension-its identification and epidemiology. Nat Rev Nephrol. 2013; 9, 51-58.
4. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation. 1998; 97, 2099-2100.
5. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999; 100, 1134-1146.
6. Rosendorff C, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007; 115, 2761-2788.
7. Go AS, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014; 129, e28-e292.
8. Gross LS, et al. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr. 2004; 79, 774-779.
9. Lyon HN, Hirschhorn JN. Genetics of common forms of obesity: a brief overview. Am J Clin Nutr. 2005; 82, 215S-217S.
10. Rodriguez-Ventura AL, et al. Barriers to lose weight from the perspective of children with overweight/obesity and their parents: a sociocultural approach. J Obes. 2014; 2014, 575184.
11. Herman KM, et al. Combined physical activity/sedentary behaviour associations with indices of adiposity in 8 to 10 year old children. J Phys Act Health. 2015; 12, 20-29.
12. Teo K, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle-and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. JAMA. 2013; 309, 1613-1621.
13. Talmud PJ, Cooper JA, Morris RW, et al. Sixty-five common genetic variants and prediction of type 2 diabetes. Diabetes. 2015; 64, 1830-1840.
14. Barker DJ, et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989; 298, 564-567.
15. Barker DJ, Osmond C, Law CM. The intrauterine and early postnatal origins of cardiovascular disease and chronic bronchitis. J Epidemiol Community Health. 1989; 43, 237-240.
16. Barker DJ, et al. Weight in infancy and death from ischaemic heart disease. Lancet. 1989; 2, 577-580.
17. Smith LP, et al. Trends in US home food preparation and consumption: analysis of national nutrition surveys and time use studies from 1965-1966 to 2007-2008. Nutr J. 2013; 12, 45-55.
18. Syddall HE, et al. Cohort profile: the Hertfordshire cohort study. Int J Epidemiol. 2005; 34, 1234-1242.
19. Andersen LG, et al. Birth weight, childhood body mass index and risk of coronary heart disease in adults: combined historical cohort studies. PLoS One. 2010; 5, e14126.
20. Barker DJ, et al. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002; 31, 1235-1239.
21. Leon DA, et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ. 1998; 317, 241-245.
22. Fan Z, et al. Relationship between birth size and coronary heart disease in China. Ann Med. 2010; 42, 596-602.
23. Stein CE, et al. Fetal growth and coronary heart disease in south India. Lancet. 1996; 348, 1269-1273.
24. Rich-Edwards JW, et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ. 1997; 315, 396-400.
25. Eriksson JG, et al. Mother's body size and placental size predict coronary heart disease in men. Eur Heart J. 2011; 32, 2297-2303.
26. Barker DJ, et al. The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood. Eur J Heart Fail. 2010; 12, 819-825.
27. Barker DJ, et al. The placental origins of sudden cardiac death. Int J Epidemiol. 2012; 41, 1394-1399.
28. Martyn CN, Barker DJ, Osmond C. Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet. 1996; 348, 1264-1268.
29. Langley-Evans SC, Phillips GJ, Jackson AA. In utero exposure to maternal low protein diets induces hypertension in weanling rats, independently of maternal blood pressure changes. Clin Nutr. 1994; 13, 319-324.
30. Barker DJ, Thornburg KL. The obstetric origins of health for a lifetime. Clin Obstet Gynecol. 2013; 56, 511-519.
31. Aiken CE, Ozanne SE. Transgenerational developmental programming. Hum Reprod Update. 2014; 20, 63-75.
32. Fleming TP, et al. Nutrition of females during the peri-conceptional period and effects on foetal programming and health of offspring. Anim Reprod Sci. 2012; 130, 193-197.
33. Watkins AJ, Lucas ES, Fleming TP. Impact of the periconceptional environment on the programming of adult disease. J Dev Orig Health Dis. 2010; 1, 87-95.
34. Watkins AJ, et al. Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring. J Physiol. 2008; 586, 2231-2244.
35. Watkins AJ, et al. Maternal periconceptional and gestational low protein diet affects mouse offspring growth, cardiovascular and adipose phenotype at 1 year of age. PLoS One. 2011; 6, e28745.
36. Kwong WY, et al. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development. 2000; 127, 4195-4202.
37. Valenzuela-Alcaraz B, et al. Assisted reproductive technologies are associated with cardiovascular remodeling in utero that persists postnatally. Circulation. 2013; 128, 1442-1450.
38. Scherrer U, et al. Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies. Circulation. 2012; 125, 1890-1896.
39. Eskild A, Monkerud L, Tanbo T. Birthweight and placental weight; do changes in culture media used for IVF matter? Comparisons with spontaneous pregnancies in the corresponding time periods. Hum Reprod. 2013; 28, 3207-3214.
40. Kleijkers SH, et al. IVF culture medium affects post-natal weight in humans during the first 2 years of life. Hum Reprod. 2014; 29, 661-669.
41. Padhee M, et al. The periconceptional environment and cardiovascular disease: does in vitro embryo culture and transfer influence cardiovascular development and health? Nutrients. 2015; 7, 1378-1425.
42. Thornburg KL, O'Tierney PF, Louey S. Review: the placenta is a programming agent for cardiovascular disease. Placenta. 2010; 31, S54-S59.
43. Godfrey KM. The role of the placenta in fetal programming-a review. Placenta. 2002; 23, S20-S27.
44. Barker DJ, et al. Fetal and placental size and risk of hypertension in adult life. BMJ. 1990; 301, 259-262.
45. Barker DJ, et al. The surface area of the placenta and hypertension in the offspring in later life. Int J Dev Biol. 2010; 54, 525-530.
46. van Abeelen AF, et al. The sex-specific effects of famine on the association between placental size and later hypertension. Placenta. 2011; 32, 694-698.
47. Roseboom TJ, et al. Effects of famine on placental size and efficiency. Placenta. 2011; 32, 395-399.
48. Alwasel SH, et al. Changes in placental size during Ramadan. Placenta. 2010; 31, 607-610.
49. Alwasel SH, et al. The breadth of the placental surface but not the length is associated with body size at birth. Placenta. 2012; 33, 619-622.
50. Alwasel SH, et al. Intergenerational effects of in utero exposure to Ramadan in Tunisia. Am J Hum Biol. 2013; 25, 341-343.
51. Alwasel SH, et al. The velocity of fetal growth is associated with the breadth of the placental surface, but not with the length. Am J Hum Biol. 2013; 25, 534-537.
52. Alwasel SH, et al. Sex differences in regional specialisation across the placental surface. Placenta. 2014; 35, 365-369.
53. Winder NR, et al. Mother's lifetime nutrition and the size, shape and efficiency of the placenta. Placenta. 2011; 32, 806-810.
54. Andersen TA, Troelsen Kde L, Larsen LA. Of mice and men: molecular genetics of congenital heart disease. Cell Mol Life Sci. 2014; 71, 1327-1352.
55. Richards AA, Garg V. Genetics of congenital heart disease. Curr Cardiol Rev. 2010; 6, 91-97.
56. Wolf M, Basson CT. The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol. 2010; 25, 192-197.
57. Ransom J, Srivastava D. The genetics of cardiac birth defects. Semin Cell Dev Biol. 2007; 18, 132-139.
58. Liu A, et al. Biomechanics of the chick embryonic heart outflow tract at HH18 using 4D optical coherence tomography imaging and computational modeling. PLoS One. 2012; 7, e40869.
59. Midgett M, Rugonyi S. Congenital heart malformations induced by hemodynamic altering surgical interventions. Front Physiol. 2014; 5, 287.
60. Hogers B, et al. Unilateral vitelline vein ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo. Circ Res. 1997; 80, 473-481.
61. Shaut CA, et al. HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification. PLoS Genet. 2008; 4, e1000073.
62. Maylie JG. Excitation-contraction coupling in neonatal and adult myocardium of cat. Am J Physiol. 1982; 242, H834-H843.
63. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004; 65, 1339-1348.
64. Luyckx VA, Brenner BM. Birth weight, malnutrition and kidney-associated outcomes-a global concern. Nat Rev Nephrol. 2015; 11, 135-149.
65. Jiang B, et al. Birth weight and cardiac structure in children. Pediatrics. 2006; 117, e257-e261.
66. Sominsky L, et al. Functional programming of the autonomic nervous system by early life immune exposure: implications for anxiety. PLoS One. 2013; 8, e57700.
67. Ward AM, Phillips DI. Fetal programming of stress responses. Stress. 2001; 4, 263-271.
68. Leeson CP, et al. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation. 2001; 103, 1264-1268.
69. Barker DJ, et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ. 1992; 304, 148-152.
70. Stacy V, et al. The influence of naturally occurring differences in birthweight on ventricular cardiomyocyte number in sheep. Anat Rec (Hoboken). 2009; 292, 29-37.
71. Barbera A, et al. Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am J Physiol Regul Integr Comp Physiol. 2000; 279, R1157-R1164.
72. Crispi F, et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation. 2010; 121, 2427-2436.
73. Dodson RB, et al. Increased arterial stiffness and extracellular matrix reorganization in intrauterine growth-restricted fetal sheep. Pediatr Res. 2013; 73, 147-154.
74. Martyn CN, Greenwald SE. A hypothesis about a mechanism for the programming of blood pressure and vascular disease in early life. Clin Exp Pharmacol Physiol. 2001; 28, 948-951.
75. Barker DJ, et al. Growth in utero and serum cholesterol concentrations in adult life. BMJ. 1993; 307, 1524-1527.
76. Napoli C, et al. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation. 2002; 105, 1360-1367.
77. Moisiadis VG, Matthews SG. Glucocorticoids and fetal programming part 2: mechanisms. Nat Rev Endocrinol. 2014; 10, 403-411.
78. Giussani DA, et al. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One. 2012; 7, e31017.
79. Giussani DA, et al. Heart disease link to fetal hypoxia and oxidative stress. Adv Exp Med Biol. 2014; 814, 77-87.
80. Morrison JL, et al. Restriction of placental function alters heart development in the sheep fetus. Am J Physiol Regul Integr Comp Physiol. 2007; 293, R306-R313.
81. Bubb KJ, et al. Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep. J Physiol. 2007; 578, 871-881.
82. Louey S, et al. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J Physiol. 2007; 580, 639-648.
83. Jonker SS, et al. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol (1985). 2007; 102, 1130-1142.
84. Pinson CW, Morton MJ, Thornburg KL. Mild pressure loading alters right ventricular function in fetal sheep. Circ Res. 1991; 68, 947-957.
85. Jonker SS, et al. Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension. Am J Physiol Regul Integr Comp Physiol. 2007; 292, R913-R919.
86. O'Tierney PF, et al. Reduced systolic pressure load decreases cell-cycle activity in the fetal sheep heart. Am J Physiol Regul Integr Comp Physiol. 2010; 299, R573-R578.
87. Fisher DJ, Heymann MA, Rudolph AM. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am J Physiol. 1980; 238, H399-H405.
88. Davis L, et al. Augmentation of coronary conductance in adult sheep made anaemic during fetal life. J Physiol. 2003; 547, 53-59.
89. Davis L, Thornburg KL, Giraud GD. The effects of anaemia as a programming agent in the fetal heart. J Physiol. 2005; 565, 35-41.
90. Yang Q, et al. Effect of fetal anaemia on myocardial ischaemia-reperfusion injury and coronary vasoreactivity in adult sheep. Acta Physiol (Oxf). 2008; 194, 325-334.
91. Li G, et al. Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat. J Soc Gynecol Investig. 2003; 10, 265-274.
92. Chattergoon NN, et al. Unexpected maturation of PI3K and MAPK-ERK signaling in fetal ovine cardiomyocytes. Am J Physiol Heart Circ Physiol. 2014; 307, H1216-H1225.
93. Giraud GD, et al. Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. Endocrinology. 2006; 147, 3643-3649.
94. Sundgren NC, et al. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am J Physiol Regul Integr Comp Physiol. 2003; 285, R1481-R1489.
95. Sundgren NC, et al. Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes. J Physiol. 2003; 548, 881-891.
96. Chattergoon NN, et al. Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J. 2012; 26, 397-408.
97. Chattergoon NN, Giraud GD, Thornburg KL. Thyroid hormone inhibits proliferation of fetal cardiac myocytes in vitro. J Endocrinol. 2007; 192, R1-R8.
98. O'Tierney PF, et al. Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes. J Physiol. 2010; 588, 2879-2889.
99. Baschat AA. Fetal responses to placental insufficiency: an update. BJOG. 2004; 111, 1031-1041.
100. Forhead AJ, et al. Developmental control of iodothyronine deiodinases by cortisol in the ovine fetus and placenta near term. Endocrinology. 2006; 147, 5988-5994.
101. Patterson AJ, et al. Chronic prenatal hypoxia induces epigenetic programming of PKC{epsilon} gene repression in rat hearts. Circ Res. 2010; 107, 365-373.
102. Chen M, Xiong F, Zhang L. Promoter methylation of Egr-1 site contributes to fetal hypoxia-mediated PKCepsilon gene repression in the developing heart. Am J Physiol Regul Integr Comp Physiol. 2013; 304, R683-R689.
103. Hata A. Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol. 2013; 75, 69-93.
104. Eulalio A, et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012; 492, 376-381.
105. Tingare A, Thienpont B, Roderick HL. Epigenetics in the heart: the role of histone modifications in cardiac remodelling. Biochem Soc Trans. 2013; 41, 789-796.
106. Messer L. Developmental programming: priming disease susceptibility for subsequent generations. 2015.